cGxP.wire https://validator.w3.org/feed/docs/rss2.html Ionis Wins FDA Approval for TRYNGOLZA in Severe Hypertriglyceridemia Revolution Medicines Presents RAS(ON) Data at ESMO 2026 HUTCHMED Reports Strong Phase II Fanregratinib Data in ICC CalciMedica Secures $49M Financing to Advance PH Program Cadrenal Highlights Phase 2 CAD-1005 Trial in Prestigious ISTH 2026 Session Viking Therapeutics Launches Phase 1 Study of VK3019 for Weight Loss Verici Dx Achieves Nationwide Access Following New York State Approval IIMU Biosciences and Waters Advance AI-Driven Immune Mapping Technology Wave Life Sciences Initiates Phase 2a INLIGHT™ Trial of WVE-007 for Obesity and Cardiometabolic Diseases Lilly Completes Centessa Deal to Accelerate Treatments for Narcolepsy and Sleep-Wake Disorders Children’s Hospital of Philadelphia Advances Targeted Cancer Immunotherapy Research AL-S Pharma Reports Positive Phase 2 AP-101 Data at ENCALS 2026 Gilead Sciences Wins FDA Approval for Trodelvy in First-Line mTNBC C Ray Therapeutics Secures Key Radiopharmaceutical License Pfizer Expands IBRANCE Label with New FDA Approval for HER2+ Breast Cancer AnaCardio Publishes AC01 Heart Failure Study in The Lancet CalciMedica Receives FDA Clearance to Continue Auxora KOURAGE Trial Quest Diagnostics Secures New York Approval for Haystack MRD Cancer Test Ollin Biosciences Announces $330M Series B to Accelerate OLN324 for DME and Wet AMD Knoa Pharma and GCAR Expand Glioblastoma Trial Efforts REPROCELL Files Japan Approval Application for Stemchymal® Sera Applauds Illinois Medicaid Coverage for PreTRM Blood Test CeleCor Submits FDA NDA for Zalunfiban After Phase 3 Success Mabwell Receives China IND Clearance for 6MW5311 Cancer Therapy Abbisko Therapeutics and Lilly Expand Global R&D Partnership Cognivia and Mayo Clinic Partner to Improve Clinical Research Outcomes Allergan Aesthetics Wins Canada Approval for Boey Neurotoxin AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C Bridge to Life Showcases VitaSmart HOPE Data at ATC 2026 Ascletis Receives FDA IND Clearance for ASC35 Obesity Trial CereVasc Completes Pivotal STRIDE Trial Enrollment for eShunt Armata Secures $2.5M DoD Funding for AP-SA02 Mediar Starts Phase 1 Trial of MTX-439 in CKD Leal Therapeutics Doses First ALS Patient with LTX-002 Calico Wins FDA Breakthrough Status for Fosigotifator Delphi Diagnostics Validates EAI for Paclitaxel Benefit Hamlet BioPharma Advances Alpha1H into Phase 3 Trial Draeger Receives FDA Clearance for Evita V800 Upgrade Phanes Completes Phase 2 Enrollment for Spevatamig in PDAC Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer Lys Therapeutics Advances LYS241 with €25M Funding Boost Genprex Strengthens REQORSA Cancer Gene Therapy Patent Pierre Fabre Secures EU Approval for BRAFTOVI in mCRC US WorldMeds Secures Full FDA Approval for TECELRA Calidi Showcases RedTail Platform at T-Cell Engager Therapeutic Summit REGENXBIO Advances NAVSUNLI Toward Accelerated Approval AbbVie to Acquire Apogee in $10.9B Immunology Expansion Murj Expands Cardiac Care Platform Across Australia and NZ MoonLake Reports Strong Phase 3 Sonelokimab HS Results AIM ImmunoTech Advances Ampligen Toward Potential Pivotal Development